Novel adaptive and innate immunity targets in hypertension

Justine M. Abais-Battad, John Henry Dasinger, Daniel J. Fehrenbach, David L. Mattson

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Hypertension is a worldwide epidemic and global health concern as it is a major risk factor for the development of cardiovascular diseases. A relationship between the immune system and its contributing role to the pathogenesis of hypertension has been long established, but substantial advancements within the last few years have dissected specific causal molecular mechanisms. This review will briefly examine these recent studies exploring the involvement of either innate or adaptive immunity pathways. Such pathways to be discussed include innate immunity factors such as antigen presenting cells and pattern recognition receptors, adaptive immune elements including T and B lymphocytes, and more specifically, the emerging role of T regulatory cells, as well as the potential of cytokines and chemokines to serve as signaling messengers connecting innate and adaptive immunity. Together, we summarize these studies to provide new perspective for what will hopefully lead to more targeted approaches to manipulate the immune system as hypertensive therapy.

Original languageEnglish (US)
Pages (from-to)109-115
Number of pages7
JournalPharmacological Research
StatePublished - Jun 1 2017
Externally publishedYes


  • Adaptive immunity
  • Antigen presenting cells
  • Hypertension
  • Innate immunity
  • Lymphocytes

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Novel adaptive and innate immunity targets in hypertension'. Together they form a unique fingerprint.

Cite this